DBV Technologies

About:

DBV Technologies focuses on the development of innovative products for the diagnosis and treatment of food allergies.

Website: http://www.dbv-technologies.com

Twitter/X: dbvtechnologies

Top Investors: Bpifrance, RA Capital Management, Apax Partners, Sofinnova Partners, Omega Funds

Description:

DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians and entrepreneurs who believed that food allergies could one day be treated safely and effectively. With this mission driving their commitment to the advancement of treatments in this field, they are investigating a potential new class of immunotherapy that aims to activate the immune system of patients through the skin.